Get started
Author

Tianyi Ye

Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice
2022 · Shant H. Mahrokhian, Lisa H. Tostanoski, et al. · npj Vaccines · 9
PDF
Inherited resilience to clonal hematopoiesis by modifying stem cell RNA regulation
2026 · Gaurav Agarwal, Mateusz Antoszewski, et al. · Science · 8
A bivalent SARS-CoV-2 monoclonal antibody combination does not affect the immunogenicity of a vector-based COVID-19 vaccine in macaques
2022 · Joseph P. Nkolola, Jingyou Yu, et al. · Science Translational Medicine · 8
Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function
2026 · Taja Vatovec, Anna-Lena Neehus, et al. · Nature Immunology · 1
Human genetics implicates a BACH2–NRF2 axis in fetal haemoglobin activation
2026 · Chun-Jie Guo, Uma P. Arora, et al. · Nature
Single-cell multiomic mapping of genetic predisposition to childhood B-cell acute lymphoblastic leukemia
2026 · Andrew J. Lee, Anna-Lena Neehus, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Mapping genetic risk mechanisms for immune-mediated diseases across human dendritic cell differentiation
2026 · Ofir Cohn, Chen Weng, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Durable and reversible epigenetic programming of human hematopoietic stem cells as a platform for modulation of platelet function
2026 · Tianyi Ye, Wanying Xu, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Supplementary Figure 3 from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026 · Lin Zhou, Kelly D. DeMarco, et al.
Table S1 and Table S2 from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026 · Lin Zhou, Kelly D. DeMarco, et al.
Supplementary Figure 4 from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026 · Lin Zhou, Kelly D. DeMarco, et al.
Supplementary Figure 7 from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026 · Lin Zhou, Kelly D. DeMarco, et al.
Supplementary Figure 1 from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026 · Lin Zhou, Kelly D. DeMarco, et al.
Supplementary Figure 8 from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026 · Lin Zhou, Kelly D. DeMarco, et al.
Supplementary Figure 2 from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026 · Lin Zhou, Kelly D. DeMarco, et al.
Supplementary Figure 5 from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026 · Lin Zhou, Kelly D. DeMarco, et al.
Supplementary Figure 6 from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026 · Lin Zhou, Kelly D. DeMarco, et al.
Data from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026 · Lin Zhou, Kelly D. DeMarco, et al.
Works count: 18
Citation count: 26
H-index: 3
I10-index:
Year
Topic
Type